Connect with us
The French pharmaceutical group Sanofi explained that the price expectations of the target did not match its criteria. Some analysts had a mixed opinions on this...
Janssen increased its profit to €72.2 million last year. In total, Johnson&Johnson expects year-end revenue to be between $93 billion and $93.5 billion, while it expects...
Bioasis Technologies Inc. has recently announced partnerships for its xB3 pharmaceutical platform with Janssen Biotech and Nueramedy, along with the acquisition of Cresence AS' Epidermal Growth...